Investigating the Synergistic Effect of the Cannabis Extract PHEC-66 and Chemotherapeutic Agents on Human Melanoma Cells
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27041794 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ava Bachari und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Pangenomics Laboratory, School of Science, RMIT University, Bundoora, VIC 3083, Australia. Hauptthemen laut MEDLINE: Melanoma, Plant Extracts, Cannabis, Antineoplastic Agents. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MGC Pharmaceuticals Ltd, MGC Pharmaceuticals Ltd., Australia.
Abstract (Originalsprache)
Melanoma is a malignant neoplasm that originates from melanocytes. It continues to pose a significant challenge in oncology due to its aggressive nature and limited treatment options. This study investigates the potential additive effects of PHEC-66, a cannabis extract, in combination with conventional chemotherapeutic agents auranofin, docetaxel, and cisplatin on the viability of a range of melanoma cell lines. These combinations were evaluated using the MTT assay on MM418-C1, MM329, C32, and D24 melanoma cells. There was a nuanced response observed when PHEC-66 was combined with docetaxel and auranofin in these cells, suggesting a potential additive effect. Contrastingly, the combination of PHEC-66 with cisplatin elicited an antagonistic effect, wherein the expected cytotoxicity of this drug was compromised. This unexpected interaction may stem from complex interplays between the agents that influence drug uptake, DNA damage response, and cell survival pathways. These findings underscore the importance of careful selection and assessment of drug combinations, as an additive effect and antagonistic interactions can significantly impact therapeutic outcomes. Further studies are warranted to elucidate the molecular mechanisms behind these interactions and to validate these observations using in vivo models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Pangenomics Laboratory, School of Science, RMIT University, Bundoora, VIC 3083, Australia.
- School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia.
- The UWA Institute of Agriculture, The University of Western Australia, Perth, WA 6009, Australia.
ORCID-Profile: Srinivasareddy Telukutla, Terrence Jerald Piva, Nitin Mantri
Förderung
- MGC Pharmaceuticals Ltd
- MGC Pharmaceuticals Ltd., Australia
Zitieren
APA
Bachari, A., Telukutla, S., Nazar, N., Piva, T. J., & Mantri, N. (2026). Investigating the Synergistic Effect of the Cannabis Extract PHEC-66 and Chemotherapeutic Agents on Human Melanoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041794
Vancouver
Bachari A, Telukutla S, Nazar N, Piva TJ, Mantri N. Investigating the Synergistic Effect of the Cannabis Extract PHEC-66 and Chemotherapeutic Agents on Human Melanoma Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041794
BibTeX
@article{Bachari2026,
author = {Bachari, Ava and Telukutla, Srinivasareddy and Nazar, Nazim and Piva, Terrence Jerald and Mantri, Nitin},
title = {Investigating the Synergistic Effect of the Cannabis Extract PHEC-66 and Chemotherapeutic Agents on Human Melanoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27041794}
}
EUVIMED